UOTTAIMCU
CDAK

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio CDAK Stock Details CDAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-847,108
Closed -$148K – 25
2023
Q1 		$148K Hold
847,108
– – 0.06% 10
2022
Q4 		$337K Hold
847,108
– – 0.13% 10
2022
Q3 		$662K Hold
847,108
– – 0.25% 11
2022
Q2 		$2.44M Hold
847,108
– – 1.06% 7
2022
Q1 		$5.31M Hold
847,108
– – 2.73% 5
2021
Q4 		$9.44M Hold
847,108
– – 4.29% 6
2021
Q3 		$13.8M Hold
847,108
– – 7.9% 5
2021
Q2 		$15.7M Hold
847,108
– – 12.04% 5
2021
Q1 		$12.8M Buy
+847,108
New +$18.4M 7.49% 5

University of Texas/Texas AM Investment Management Co (UTIMCO)'s CDAK Position: Q2 2023 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Codiak BioSciences, Inc. Common Stock (CDAK) in Q2 2023, closing a stake of 847,108 shares — an estimated $148K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in CDAK in Q1 2021 and held it in 9 quarters. The position peaked at $15.7M in Q2 2021. 1 fund tracked by Wall St. Rank holds CDAK as of Q2 2023.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Codiak BioSciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 847,108 Codiak BioSciences, Inc. Common Stock shares in Q2 2023, an estimated $148K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Codiak BioSciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Codiak BioSciences, Inc. Common Stock position peaked at $15.7M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Codiak BioSciences, Inc. Common Stock as of Q2 2023.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2023, filed 4 Aug 2023.